Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.
22.04.2025 15:07:41

EQS-News: Cavitation Technologies, Inc. Announces the Completion of Cavitation Non-Thermal Plasma System to Address the Global Water Crisis

EQS-News: Cavitation Technologies, Inc / Key word(s): Manufacturing
Cavitation Technologies, Inc. Announces the Completion of Cavitation Non-Thermal Plasma System to Address the Global Water Crisis

22.04.2025 / 15:07 CET/CEST
The issuer is solely responsible for the content of this announcement.


CHATSWORTH, CA - April 22, 2025 (NEWMEDIAWIRE) - Cavitation Technologies, Inc. (“CTi” or the “Company”) (OTCQB: CVAT), a leading nano-technology company specializing in innovative flow-through devices and systems for fluid processing applications worldwide, announces a completion of Cavitation Non-Thermal Plasma System. The Company’s disruptive water treatment technology will address the growing global demand for efficient, chemical-free water solutions.

Water Is the New Gold

The world is entering an era where clean water is more critical than ever before - not just for agriculture and drinking, but as the backbone of cutting-edge technology. Even the rise of AI (Artificial Intelligence) giants like OpenAI, Microsoft, Google DeepMind, Meta AI, and Amazon Web Services (AWS) is built on massive water consumption. For example, the researchers estimated that training the GPT-3 language model in Microsoft’s U.S. data centers can directly evaporate 700,000 liters of clean freshwater. More critically, the global AI demand is projected to account for 4.2 – 6.6 billion cubic meters of water withdrawal in 2027, which is more than the total annual water withdrawal of half of the United Kingdom.

In this rapidly shifting landscape, industrial water reuse isn’t just environmentally sustainable - it’s also a smart economic move. CTi’s water treatment systems offers substantial cost savings compared to traditional water remediation processes and disposal methods. As global freshwater scarcity increases and ESG regulations tighten, sustainable technologies developed by CTi are becoming essential.

Why Plasma Is the Future

While existing solutions like reverse osmosis (RO), UV disinfection, membrane filtration, and activated carbon adsorption play important roles in water treatment, these technologies come with limitations - from high energy demand and frequent membrane fouling to incomplete PFAS (‘forever chemicals’) removal and chemical dependency.

Researchers, universities, private companies, and even government agencies like the DoD (Department of Defense) are actively exploring plasma as a next-generation treatment technology (See page 12: Research and Development of New and Emerging Technologies for the Remediation and Disposal of PFAS). Plasma systems offer a chemical-free, low-energy method to break down contaminants that traditional systems struggle with - including PFAS, viruses, and bacteria.

“I foresee ten years down the line that plasmas will become a bit more mainstream in water treatment, just like UV light is now almost standard in most wastewater plants,” John Foster, professor of nuclear engineering and radiological sciences at the University of Michigan, a leading voice in plasma science.

Our Technology

CVAT’s patented Nano Reactor® systems - operating at scalable capacities from 10 to 500 gallons per minute (GPM) - and the company’s newest innovation, the Cavitation Non-Thermal Plasma™ , currently operating at 20 GPM and scalable to a larger flow, are driving disruptive change across the water treatment industry. These advanced systems are designed to eliminate bacteria and viruses, lower TDS levels, and provide a highly promising path for the removal of PFAS - commonly known as “forever chemicals.”

Where We’re Creating Change

CVAT’s technology have active and emerging applications in:

  • Industrial Water & Wastewater – Supporting the reuse of large water volumes by providing efficient, chemical-free treatment systems tailored for industrial operations.

  • Agriculture – Plasma-Activated Water (PAW) increases plant growth, reduces pesticide load, and lowers the need for chemical fertilizers.

  • Pharmaceuticals – Producing ultra-pure water critical for safe drug development and formulation.

  • High-Precision Electronics –Ensuring water purity standards essential for advanced component manufacturing, where even microscopic contaminants can impact performance.

  • Desalination – Helping optimize operations by improving system efficiency and longevity while reducing the need for extensive chemical handling.

  • PFAS removal Offering a promising approach to break down and eliminate persistent contaminants that traditional technologies struggle to treat effectively.

  • Military – Providing reliable and mobile solutions for water purification and reuse in remote or rapidly changing environments, with minimal logistical needs.

These industries represent a combined Total Addressable Market (TAM) of over $2.37 trillion, and CTi’s system offers a competitive advantage with low operating costs, minimal chemical use, and scalability.

Neil Voloshin, CEO, Cavitation Technologies, Inc stated, “The combination of Cavitation with Non-Thermal Plasma is what sets CTi apart - an exceptionally powerful and rare integration in the water treatment space. Over the next several months, we’ll be sharing more about the commercial steps we’re taking to scale up and expand.”

About Cavitation Technologies, Inc.

Founded in 2007, Cavitation Technologies, Inc. (OTCQB: CVAT), is a leading ESG company, that designs and manufactures innovative flow-through nano-technology systems for fluid processing applications worldwide. The technology is designed for fluids processing across multiple industries: water treatment and remediation, agriculture, pharmaceuticals, oil & gas, edible oil refining, renewable fuels, PFAS removal and beverages.

Our core products are Nano Reactor® systems, with scalable capacities ranging from 10 to 500 gallons per minute (GPM), and our latest advancement, Cavitation Non-Thermal Plasma technology, which currently operates at 20 GPM and scalable to a larger flow. These systems effectively eliminate bacteria and viruses, reduce TDS levels, lower turbidity, and offer the potential removal of PFAS in multiple water remediation applications.

CTi holds over 40 patents issued domestically and internationally.

https://www.cvatinfo.com/
https://ctinanotech.com/
www.hydroplasma.tech

Follow our social media for real time updates:

Twitter: https://twitter.com/CavitationTech
LinkedIn: http://linkedin.com/company/cavitation-technologies
YouTube: https://www.youtube.com/@cvatinfo

Forward-Looking Statement

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, forward-looking statements can be identified by terminology such as ''may,'' ''should,'' ''potential,'' ''continue,'' ''expects,'' ''anticipates,'' ''intends,'' ''plans,'' ''believes,'' ''estimates,'' and similar expressions. These forward-looking statements are based largely on the Company's expectations and are subject to a number of risks and uncertainties, certain of which are beyond the Company's control. Actual results could differ materially from these forward-looking statements as a result of a variety of factors including, among others, our ability to perform the installation as anticipated, the state of the economy, the competitive environment and other factors described in our most recent Form 10-K and our other filings with the SEC, including subsequent periodic reports on Forms 10-Q and 8-K. In light of these risks and uncertainties there can be no assurances that the forward-looking statements contained in this press release will in fact transpire or prove to be accurate. The information in this release is provided only as of the date of this release, and we undertake no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.

Cavitation Technologies, Inc.
818-718-0905
info@ctinanotech.com

View the original release on www.newmediawire.com


News Source: Cavitation Technologies, Inc


22.04.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Cavitation Technologies, Inc
United States
ISIN: US14964W1045
EQS News ID: 2121632

 
End of News EQS News Service

2121632  22.04.2025 CET/CEST

Analysen zu Cavitation Technologies Inc

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
Zu diesem Datensatz liegen uns leider keine Daten vor.
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

3 Knaller-Aktien im BX Musterportfolio📈: Thales, Generali & Swiss Life mit François Bloch

Im BX Morningcall werden folgende Aktien analysiert und erklärt:
📌 Thales Group (FR0000121329)
📌 Assicurazioni Generali (IT0000062072)
📌 Swiss Life Holding (CH0014852781)

➡️ Ausserdem zeigen wir, welche Aktien das Portfolio verlassen haben und warum:
❌ Meta Platforms (US30303M1027)
❌ LPL Financial (US50212V1008)
❌ American Express (US0258161092)

Pünktlich zum Börsenstart diskutieren Investment-Stratege François Bloch und Börsen-Experte David Kunz oder Olivia Hähnel über ausgewählte Top-Aktienwerte aus dem BX Musterportfolio.

👉🏽 https://bxplus.ch/bx-musterportfolio/

3 Knaller-Aktien im BX Musterportfolio📈: Thales, Generali & Swiss Life | Rebalancing im #BXMusterportfolio

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 12’320.74 18.31 B7RS6U
Short 12’560.06 13.42 BKFSAU
Short 12’996.38 8.91 BVKSPU
SMI-Kurs: 12’233.03 05.05.2025 17:30:52
Long 11’640.00 19.68
Long 11’387.51 11.46 B74SQU
Long 10’640.00 7.42
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com

finanzen.net News

Datum Titel
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
{{ARTIKEL.NEWS.BODY.TITEL}}